These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25326645)

  • 21. STAT3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target.
    Al-Hetty HRAK; Abdulameer SJ; Alkubaisy SA; Zaid SA; Jalil AT; Jasim IK
    Pathol Res Pract; 2023 May; 245():154425. PubMed ID: 37019018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
    Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
    Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
    Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
    Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer.
    Arima K; Komohara Y; Bu L; Tsukamoto M; Itoyama R; Miyake K; Uchihara T; Ogata Y; Nakagawa S; Okabe H; Imai K; Hashimoto D; Chikamoto A; Yamashita YI; Baba H; Ishimoto T
    Cancer Sci; 2018 Feb; 109(2):462-470. PubMed ID: 29224225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma.
    Fan CS; Chen LL; Hsu TA; Chen CC; Chua KV; Li CP; Huang TS
    J Hematol Oncol; 2019 Dec; 12(1):138. PubMed ID: 31847880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
    Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
    Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.
    Lerner I; Hermano E; Zcharia E; Rodkin D; Bulvik R; Doviner V; Rubinstein AM; Ishai-Michaeli R; Atzmon R; Sherman Y; Meirovitz A; Peretz T; Vlodavsky I; Elkin M
    J Clin Invest; 2011 May; 121(5):1709-21. PubMed ID: 21490396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow.
    Grünwald B; Vandooren J; Gerg M; Ahomaa K; Hunger A; Berchtold S; Akbareian S; Schaten S; Knolle P; Edwards DR; Opdenakker G; Krüger A
    Mol Cancer Res; 2016 Nov; 14(11):1147-1158. PubMed ID: 27489361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.
    Kalbasi A; Komar C; Tooker GM; Liu M; Lee JW; Gladney WL; Ben-Josef E; Beatty GL
    Clin Cancer Res; 2017 Jan; 23(1):137-148. PubMed ID: 27354473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression.
    Liu Y; Wang X; Zhu Y; Cao Y; Wang L; Li F; Zhang Y; Li Y; Zhang Z; Luo J; Deng X; Peng C; Wei G; Chen H; Shen B
    Clin Transl Med; 2022 Feb; 12(2):e654. PubMed ID: 35184402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling.
    Kühnemuth B; Mühlberg L; Schipper M; Griesmann H; Neesse A; Milosevic N; Wissniowski T; Buchholz M; Gress TM; Michl P
    Oncogene; 2015 Jan; 34(2):177-87. PubMed ID: 24336331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.
    Cho K; Matsuda Y; Ueda J; Uchida E; Naito Z; Ishiwata T
    Int J Oncol; 2012 Apr; 40(4):1040-8. PubMed ID: 22159401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma.
    Goldberg R; Meirovitz A; Abecassis A; Hermano E; Rubinstein AM; Nahmias D; Grinshpun A; Peretz T; Elkin M
    Front Oncol; 2019; 9():1405. PubMed ID: 31921662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
    Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
    Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma.
    Ye H; Zhou Q; Zheng S; Li G; Lin Q; Wei L; Fu Z; Zhang B; Liu Y; Li Z; Chen R
    Cell Death Dis; 2018 May; 9(5):453. PubMed ID: 29670110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer.
    Kato H; Naiki-Ito A; Suzuki S; Inaguma S; Komura M; Nakao K; Naiki T; Kachi K; Kato A; Matsuo Y; Takahashi S
    Carcinogenesis; 2021 Jul; 42(7):940-950. PubMed ID: 33640964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma.
    Long KB; Gladney WL; Tooker GM; Graham K; Fraietta JA; Beatty GL
    Cancer Discov; 2016 Apr; 6(4):400-413. PubMed ID: 26896096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression.
    Blich M; Golan A; Arvatz G; Sebbag A; Shafat I; Sabo E; Cohen-Kaplan V; Petcherski S; Avniel-Polak S; Eitan A; Hammerman H; Aronson D; Axelman E; Ilan N; Nussbaum G; Vlodavsky I
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):e56-65. PubMed ID: 23162016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma.
    Rohloff J; Zinke J; Schoppmeyer K; Tannapfel A; Witzigmann H; Mössner J; Wittekind C; Caca K
    Br J Cancer; 2002 Apr; 86(8):1270-5. PubMed ID: 11953884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.